Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) that comprises a monoclonal antibody specific to CD33 conjugated to a cytotoxic agent derived from Calicheamicin. It is utilized in the investigation of acute myeloid leukemia [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) that comprises a monoclonal antibody specific to CD33 conjugated to a cytotoxic agent derived from Calicheamicin. It is utilized in the investigation of acute myeloid leukemia [1]. |
Molecular Weight | N/A |
CAS No. | 220578-59-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemtuzumab ozogamicin 220578-59-6 inhibitor inhibit